FIELD: medicine.
SUBSTANCE: cathelicidin LL 37 is measured in a single portion of pharyngeal aspirate on the 1st-2nd day of life. If cathelicidin LL 37 is equal to 10.2 ng/ml or more, the favourable clinical outcome of congenital pneumonia in small premature infants is predicted, while the measured value of less than 10.2 ng/ml shows the lethal outcome.
EFFECT: method enables high-accuracy prediction of the clinical outcomes of congenital pneumonia in small premature infants, the timely correction and enhancement of the prescribed therapy and thereby the improvement of the clinical outcome that leads to reducing the cost of treatment and prevents the further health conditions of the infant.
1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INFECTIOUS AND INFLAMMATORY PATHOLOGY OUTCOMES PREDICTION FOR EXTREMELY PREMATURE INFANTS | 2016 |
|
RU2619343C1 |
| METHOD FOR EARLY PREDICTION OF DEVELOPING NEONATAL PNEUMONIA IN PREMATURE INFANTS WITH EXTREMELY LOW AND VERY LOW BODY WEIGHT | 2020 |
|
RU2738577C1 |
| METHOD OF PREDICTING BRONCHOPULMONARY DISPLASIA IN CHILDREN WITH INHERENT PNEUMONIA | 2010 |
|
RU2439569C1 |
| METHOD FOR ASSESSING CLINICAL EFFECTIVENESS IN TREATING PNEUMONIA IN NEWBORNS WITH VERY LOW OR EXTREMELY LOW BODY WEIGHT | 2013 |
|
RU2525438C1 |
| METHOD FOR EARLY PREDICTION OF PNEUMONIAS IN SMALL PREMATURE NEWBORNS SUFFERING RESPIRATORY DISTRESS SYNDROME | 2011 |
|
RU2463607C1 |
| METHOD FOR PREDICTION OF RESPIRATORY DISORDERS IN NEWBORNS BORN IN MOTHERS WITH PREECLAMPSIA | 2019 |
|
RU2693830C1 |
| METHOD FOR PREDICTING THE RESULT AFTER SEVERE FORMS OF NEONATAL INFECTIONS | 2003 |
|
RU2257585C2 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF A SEVERE COURSE OF NEONATAL DISTRIBUTIVE SHOCK IN VERY PREMATURE INFANTS WITH A BIRTH WEIGHT OF LESS THAN 1500 G | 2021 |
|
RU2754731C1 |
| METHOD FOR PREDICTION OF EARLY ANAEMIA OF PREMATURE NEWBORNS | 2019 |
|
RU2719657C1 |
| METHOD FOR PREDICTION OF EARLY ANEMIA OF PREMATURE NEWBORNS | 2019 |
|
RU2699657C1 |
